Celldex Therapeutics Stock Technical Analysis

CLDX Stock  USD 37.98  0.55  1.43%   
As of the 20th of April, Celldex Therapeutics shows the Risk Adjusted Performance of 0.0111, downside deviation of 2.62, and Mean Deviation of 2.46. Celldex Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down nineteen technical drivers for Celldex Therapeutics, which can be compared to its peers. Please confirm Celldex Therapeutics downside deviation, jensen alpha, as well as the relationship between the Jensen Alpha and downside variance to decide if Celldex Therapeutics is priced correctly, providing market reflects its regular price of 37.98 per share. Given that Celldex Therapeutics has jensen alpha of (0.07), we suggest you to validate Celldex Therapeutics's prevailing market performance to make sure the company can sustain itself at a future point.

Celldex Therapeutics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Celldex, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Celldex
  
Celldex Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Celldex Therapeutics Analyst Consensus

Target PriceAdvice# of Analysts
59.57Strong Buy8Odds
Celldex Therapeutics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Celldex analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Celldex stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Celldex Therapeutics, talking to its executives and customers, or listening to Celldex conference calls.
Celldex Analyst Advice Details
Celldex Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Celldex Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Celldex Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Celldex Therapeutics Technical Analysis

Indicator
Time Period
Execute Indicator
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Celldex Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Celldex Therapeutics Trend Analysis

Use this graph to draw trend lines for Celldex Therapeutics. You can use it to identify possible trend reversals for Celldex Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Celldex Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Celldex Therapeutics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Celldex Therapeutics applied against its price change over selected period. The best fit line has a slop of   0.05  , which means Celldex Therapeutics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 82.96, which is the sum of squared deviations for the predicted Celldex Therapeutics price change compared to its average price change.

About Celldex Therapeutics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Celldex Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Celldex Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Celldex Therapeutics price pattern first instead of the macroeconomic environment surrounding Celldex Therapeutics. By analyzing Celldex Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Celldex Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Celldex Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2021 2022 2023 2024 (projected)
Graham Number19.0320.2524.1222.91
Receivables Turnover27.046.791.521.44

Celldex Therapeutics April 20, 2024 Technical Indicators

Most technical analysis of Celldex help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Celldex from various momentum indicators to cycle indicators. When you analyze Celldex charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
When determining whether Celldex Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Celldex Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Celldex Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Celldex Therapeutics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celldex Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
For more information on how to buy Celldex Stock please use our How to Invest in Celldex Therapeutics guide.
Note that the Celldex Therapeutics information on this page should be used as a complementary analysis to other Celldex Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for Celldex Stock analysis

When running Celldex Therapeutics' price analysis, check to measure Celldex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celldex Therapeutics is operating at the current time. Most of Celldex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Celldex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celldex Therapeutics' price. Additionally, you may evaluate how the addition of Celldex Therapeutics to your portfolios can decrease your overall portfolio volatility.
CEOs Directory
Screen CEOs from public companies around the world
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Is Celldex Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Celldex Therapeutics. If investors know Celldex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Celldex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.92)
Revenue Per Share
0.142
Quarterly Revenue Growth
1.561
Return On Assets
(0.22)
Return On Equity
(0.37)
The market value of Celldex Therapeutics is measured differently than its book value, which is the value of Celldex that is recorded on the company's balance sheet. Investors also form their own opinion of Celldex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Celldex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Celldex Therapeutics' market value can be influenced by many factors that don't directly affect Celldex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Celldex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Celldex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Celldex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.